KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology
KUH-ART:肾脏疾病、泌尿科和血液学高级研究培训
基本信息
- 批准号:10657816
- 负责人:
- 金额:$ 46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcademiaAdultAdvocacyAllyAreaBasic ScienceBenignBiomedical EngineeringBiotechnologyCaliforniaCellular biologyChildhoodClinicalClinical SciencesCollaborationsCommunicationCommunitiesComputational BiologyCreativenessDevelopmentDevelopmental BiologyDoctor of PhilosophyE-learningEducational CurriculumEducational StatusEndocrinologyEngineeringEpidemiologyEvaluationExposure toFellowshipFundingFutureGeographyGoalsGrantHealthHealth Services ResearchHematologyIncentivesInfrastructureInstitutionInstructionIron Metabolism DisordersKidneyKidney DiseasesKidney TransplantationLeadLeadershipLocationLos AngelesManuscriptsMaster of ScienceMeasuresMedicalMedical centerMedicineMentorsMentorshipNational Heart, Lung, and Blood InstituteNational Institute of Diabetes and Digestive and Kidney DiseasesNephrologyOutcomePediatric HematologyPharmacologyPhysiciansPhysiologyPostdoctoral FellowPreparationProcessProductivityProfessional CompetenceProgram EffectivenessPublic HealthRecording of previous eventsResearchResearch PersonnelResearch TrainingResourcesScholars ProgramScienceScientistSeriesSocial SciencesStudentsSupervisionTalentsTechnologyTraineeshipTrainingTraining ProgramsTranslational ResearchUnited States National Institutes of HealthUniversitiesUrologyVocational Guidancecareerdoctoral studenteducation researcheducational atmospheregraduate studenthigh schoolimprovedinnovationinter-institutionalinterestiron metabolismlecturesmalemedical schoolsmedical specialtiesmetropolitanminority healthmultidisciplinaryoutreach programpatient populationpre-doctoralprogramsrecruitsymposiumurologic
项目摘要
Overall Abstract
Under a multi-PI leadership with an established track record of scientific and mentorship collaboration, we
propose a comprehensive Los Angeles metropolitan area-based interdisciplinary graduate and postgraduate
training program (KUH-Advanced Research Training or KUH-ART). The overarching objective of this program
is to prepare trainees for long-term productive careers in high-impact research in benign nephrology, urology
and hematology. To achieve this goal, we will:
1) Recruit outstanding and diverse pre- and postdoctoral students. We will reach out through multiple
media and programs to students and trainees at all levels, nationwide, and through fellowship matching
programs in the KUH area, highlighting the attractive opportunities in the KUH-ART research space
2) Develop and support a personalized guidance program, matching interested trainees with research
mentors and labs. We will provide (a) easy-to-access general mentoring support and trainee advocacy, (b)
career guidance and general research career skills (manuscript and grant preparation, collaboration, scientific
communication, and networking) through partnerships with existing programs under UCLA-CTSI, and (c)
trainee exposure to the array of available research careers from academia to biotechnology and pharma.
3) Incentivize the development and support of specific educational research-oriented KUH content for
KUH trainees at all levels, leveraging existing seminar series, courses and conferences. We will
construct and evolve a virtual learning environment (VLE) that facilitates formal and informal interactions
among our trainees, with mentors, and with trainees at other similar programs. We will develop new
instructional content specific to the needs of our trainees. We will facilitate the participation of KUH trainees
in broader scholarly communities according to their level of training (MSTP, graduate student lecture series
and seminars, CTSI KL2 courses), and introduce KUH content into these activities.
4) Measure and evaluate quality and outcomes to assess program effectiveness. Guided by our external
and internal advisory boards, we will use the evaluation process for continuous quality improvement in
curricular offerings, the learning environment, and trainee outcomes.
KUH-ART will benefit from strong institutional support that will allow us to integrate existing resources and
consolidate productive interinstitutional relationships. The geographic footprint and infrastructure of KUH-ART
will build on the highly successful UCLA Clinical and Translational Science Institute, a research partnership of
leading local institutions: UCLA, Cedars-Sinai Medical Center, Charles R. Drew University of Medicine and
Science and Harbor-UCLA Medical Center/Lundquist Institute for Biomedical Innovation. Successful
implementation of KUH-ART will assure that diverse and talented biomedical trainees in the Los Angeles
metropolitan area are recruited and optimally trained to contribute to solving important problems in the KUH area.
总体抽象
在多人领导领导下,具有科学和指导协作的既定记录,我们
提出一个综合的洛杉矶大都会区跨学科研究生和研究生
培训计划(Kuh-Advanced研究培训或Kuh-Art)。该计划的总体目标
是为学员准备长期生产职业的良性肾脏学高影响力研究的长期职业
和血液学。为了实现这一目标,我们将:
1)招募杰出和多样的博士后学生。我们将通过多个
媒体和计划在全国各地的各个级别的学生和学员,以及通过奖学金匹配
Kuh地区的计划,强调了Kuh-Art研究领域的吸引力机会
2)制定和支持个性化的指导计划,将有兴趣的受训者与研究相匹配
导师和实验室。我们将提供(a)易于访问的一般指导支持和学员的倡导,(b)
职业指导和一般研究职业技能(手稿和赠款准备,协作,科学
通过与UCLA-CTSI下的现有计划的合作伙伴关系,(c)
受训者接触从学术界到生物技术和制药的一系列可用研究职业。
3)激励特定的面向教育研究的kuh内容的开发和支持
库赫(Kuh)在各个层面的学员,利用现有的研讨会系列,课程和会议。我们将
构建和发展一个虚拟学习环境(VLE),以促进正式和非正式互动
在我们的学员,导师和其他类似计划的学员中。我们将开发新的
教学内容特定于我们受训者的需求。我们将促进Kuh受训者的参与
根据他们的培训水平(MSTP,研究生讲座系列),在更广泛的学术社区中
和研讨会,CTSI KL2课程),并将Kuh内容引入这些活动。
4)衡量和评估质量和结果以评估程序有效性。在我们的外部指导下
和内部咨询委员会,我们将使用评估过程进行持续的质量改进
课程产品,学习环境和学员成果。
Kuh-Art将受益于强大的机构支持,这将使我们能够整合现有资源和
巩固生产的机构间关系。 Kuh-Art的地理足迹和基础设施
将建立在非常成功的UCLA临床和转化科学学院,这是一个研究合作伙伴关系
领先的当地机构:加州大学洛杉矶分校,雪松 - 西奈医学中心,查尔斯·R·德鲁大学医学院和
科学和港口 - 乌克兰医学中心/伦德奎斯特生物医学创新研究所。成功的
实施Kuh-Art将确保洛杉矶的多样化和才华横溢的生物医学学员
对大都市地区进行了招募和最佳培训,以解决在Kuh地区解决重要问题的贡献。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The growing implications of obesity for prostate cancer risk and mortality: where do we go from here?
肥胖对前列腺癌风险和死亡率的影响越来越大:我们该何去何从?
- DOI:10.1093/jnci/djad140
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Daniels,JamesPercy;Freedland,StephenJ;Gresham,Gillian
- 通讯作者:Gresham,Gillian
Investigating trends in interest for benign prostatic hyperplasia surgery options using Google Trends.
使用 Google 趋势调查对良性前列腺增生手术选择的兴趣趋势。
- DOI:10.1038/s41391-023-00692-0
- 发表时间:2024
- 期刊:
- 影响因子:4.8
- 作者:Daniels,JamesP;Patel,DevinN;Galvan,GloriaCecilia;Friedrich,NadineA;Das,Sanjay;Akhavein,Arash;Daskivich,Timothy;Josephson,David;Desai,Premal;DeNunzio,Cosimo;Freedland,StephenJ
- 通讯作者:Freedland,StephenJ
Osteopontin as a Biomarker in Chronic Kidney Disease.
- DOI:10.3390/biomedicines11051356
- 发表时间:2023-05-04
- 期刊:
- 影响因子:4.7
- 作者:
- 通讯作者:
27-hydroxycholesterol and DNA damage repair: implication in prostate cancer.
- DOI:10.3389/fonc.2023.1251297
- 发表时间:2023
- 期刊:
- 影响因子:4.7
- 作者:
- 通讯作者:
Characterization of erythroferrone structural domains relevant to its iron-regulatory function.
- DOI:10.1016/j.jbc.2023.105374
- 发表时间:2023-12
- 期刊:
- 影响因子:4.8
- 作者:Srole, Daniel N.;Jung, Grace;Waring, Alan J.;Nemeth, Elizabeta;Ganz, Tomas
- 通讯作者:Ganz, Tomas
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen Jay Freedland其他文献
Stephen Jay Freedland的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen Jay Freedland', 18)}}的其他基金
A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment
一项针对新诊断胶质母细胞瘤患者的生酮饮食与标准护理治疗相结合的随机对照 2 期研究
- 批准号:
10568656 - 财政年份:2023
- 资助金额:
$ 46万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
10381279 - 财政年份:2021
- 资助金额:
$ 46万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
9889065 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
10116314 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
10376281 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
10524093 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mitigating Long-term Cardiotoxicity with Nanoparticle Encapsulated Anthracyclines
用纳米颗粒封装的蒽环类药物减轻长期心脏毒性
- 批准号:
10378678 - 财政年份:2021
- 资助金额:
$ 46万 - 项目类别:
Mitigating Long-term Cardiotoxicity with Nanoparticle Encapsulated Anthracyclines
用纳米颗粒封装的蒽环类药物减轻长期心脏毒性
- 批准号:
10195941 - 财政年份:2021
- 资助金额:
$ 46万 - 项目类别:
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology
KUH-ART:肾脏疾病、泌尿科和血液学高级研究培训
- 批准号:
10285905 - 财政年份:2021
- 资助金额:
$ 46万 - 项目类别:
Consortium for Autism, Neurodevelopmental Disorders, andDigestive Diseases (CANDID)
自闭症、神经发育障碍和消化系统疾病联盟 (CANDID)
- 批准号:
10318503 - 财政年份:2021
- 资助金额:
$ 46万 - 项目类别: